Global Markets and Technologies for Optical Coherence Tomography (OCT)

Report Highlights

The global market for optical coherence tomography technologies reached $722.7 million and $795.4 million in 2013 and 2014, respectively. This market is forecasted to grow at a compound annual growth rate (CAGR) of 7.9% to reach nearly $1.2 billion in 2019.

Report Includes

• An overview of the global market for optical coherence tomography (OCT), including details on system technology segments: traditional (time domain), frequency domain, and other modes of OCT measurement.
• Analyses of global market trends, with data from 2013 and 2014 and projections of CAGRs through 2019.
• A breakdown of OCT formats, including office/tabletop, catheter-based, and handheld.
• Regulatory status of the devices in the U.S., EU, and other regions.
• Delineation of the major markets for the technology, including ophthalmology, cardiovascular, oncology, dermatology, and dental applications.

SCOPE OF THE STUDY

BCC Research conducted a market evaluation of the available OCT technology and shows the global and regional breakdown of sales data, OCT applications in the commercial and research arenas, as well as existing regulation for the sector. The report also highlights current patents in OCT technologies, industry leaders and their share of the market, and the category sizes for OCT systems, products, platforms and techniques. The report summarizes the global OCT market by category and region. North America (U.S. and Canada), Europe and emerging markets (Asian countries, South America, parts of Africa, Russia etc.) are considered for the geographical market analysis. The application of OCT techniques is based on various medical and non-medical applications such as ophthalmology, cardiology, oncology, dentistry, art, environmental science, food and others.

Statistical analyses of global and regional OCT markets’ sales data were used to verify present and projected values. The technology details in the report are based on their present and possible application, practicality and suitability.

Analyst Credentials

Shalini Shahani Dewan focuses on pharmaceuticals and biotechnology and has been a BCC Research contributor since 2002 as both an analyst and project manager. She has explored a wide range of topics and companies, including working for Johnson & Johnson doing market surveillance. She has an undergraduate degree in pharmacy and master's degree in medicinal chemistry. She resides in the Bay Area.